Dotzauer A, Gebhardt U, Bieback K, Göttke U, Kracke A, Mages J, Lemon S M, Vallbracht A
Department of Virology, University of Bremen, D-28359 Bremen, Germany.
J Virol. 2000 Dec;74(23):10950-7. doi: 10.1128/jvi.74.23.10950-10957.2000.
The mechanisms underlying the hepatotropism of hepatitis A virus (HAV) and the relapsing courses of HAV infections are unknown. In this report, we show for a mouse hepatocyte model that HAV-specific immunoglobulin A (IgA) mediates infection of hepatocytes with HAV via the asialoglycoprotein receptor, which binds and internalizes IgA molecules. Proof of HAV infection was obtained by detection of HAV minus-strand RNA, which is indicative for virus replication, and quantification of infectious virions. We demonstrate that human hepatocytes also ingest HAV-anti-HAV IgA complexes by the same mechanism, resulting in infection of the cells, by using the HepG2 cell line and primary hepatocytes. The relevance of this surrogate receptor mechanism in HAV pathogenesis lies in the fact that HAV, IgA, and antigen-IgA complexes use the same pathway within the organism, leading from the gastrointestinal tract to the liver via blood and back to the gastrointestinal tract via bile fluid. Therefore, HAV-specific IgA antibodies produced by gastrointestinal mucosa-associated lymphoid tissue may serve as carrier and targeting molecules, enabling and supporting HAV infection of IgA receptor-positive hepatocytes and, in the case of relapsing courses, allowing reinfection of the liver in the presence of otherwise neutralizing antibodies, resulting in exacerbation of liver disease.
甲型肝炎病毒(HAV)嗜肝性及HAV感染复发过程的潜在机制尚不清楚。在本报告中,我们在小鼠肝细胞模型中发现,HAV特异性免疫球蛋白A(IgA)通过去唾液酸糖蛋白受体介导HAV感染肝细胞,该受体可结合并内化IgA分子。通过检测指示病毒复制的HAV负链RNA及定量感染性病毒粒子来证实HAV感染。我们利用HepG2细胞系和原代肝细胞证明,人类肝细胞也通过相同机制摄取HAV-抗-HAV IgA复合物,导致细胞感染。这种替代受体机制在HAV发病机制中的相关性在于,HAV、IgA和抗原-IgA复合物在生物体内使用相同途径,即从胃肠道经血液至肝脏,再经胆汁返回胃肠道。因此,胃肠道黏膜相关淋巴组织产生的HAV特异性IgA抗体可能作为载体和靶向分子,促成并支持IgA受体阳性肝细胞的HAV感染,在复发过程中,在存在其他中和抗体的情况下允许肝脏再次感染,导致肝病加重。